Galectin Therapeutics Inc. Units

(GALTU) Trade

By |

Profile

Galectin Therapeutics Inc is a biotechnology company. The company is focused on discovery and development. It is engaged in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of directly involved in multiple inflammatory, fibrotic, and malignant diseases. The lead development program is in non-alcoholic steatohepatitis (NASH) with cirrhosis, the most advanced form of NASH-related fibrosis.

Contact Information

Website: www.galectintherapeutics.com
Email: ir@galectintherapeutics.com
Main Phone: +1 678 620-3186
Address: 4960 Peachtree Industrial Boulevard
Address 2: Suite 240
State: GA
City / Town: Norcross
Country: USA
Postal Code: 30071

Issuer Information

Exchange: NSC
CEO: Harold H. Shlevin
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 19.20 52 Wk Low 1.13
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange NCM